BrainsWay Broadens Partnership with Katie’s Way Plus Through Order of an Additional 18 Deep TMS™ Systems
18 mars 2024 07h30 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, March 18, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights
06 mars 2024 07h30 HE
|
BrainsWay
Generated Record Revenues with Robust 50% Year-over-Year Revenue Growth in Q4 2023; Generated Positive Quarterly Net Income Providing Full-Year 2024 Revenue Guidance of $37-$40 Million with Continued...
BrainsWay to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024
21 févr. 2024 08h00 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Feb. 21, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology
10 janv. 2024 07h30 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Jan. 10, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network
19 déc. 2023 07h30 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Dec. 19, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay Announces Continued Expansion of Deep TMS™ in South Korea
07 déc. 2023 08h00 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Dec. 07, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
Louisiana Insurer Expands Deep TMS™ Access for 1.9 Million Covered Lives
20 nov. 2023 07h30 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Nov. 20, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay Reports Third Quarter 2023 Financial Results and Operational Highlights
15 nov. 2023 07h30 HE
|
BrainsWay
Generated Robust 61% Year-over-Year Revenue Growth in Q3 2023 Nearing Breakeven Operating Income, Achieved Positive Adjusted EBITDA, with Cash Flow from Operations Exceeding $1 Million Conference...
Clinical TMS Society Publishes First Coverage Recommendations for the Treatment of Smoking Addiction
02 nov. 2023 08h00 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Nov. 02, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay to Report Third Quarter 2023 Financial Results on November 15, 2023
01 nov. 2023 08h00 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Nov. 01, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...